Wanze, Belgium

Gilles Dufour


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilles Dufour: Innovator in Pharmaceutical Compositions

Introduction

Gilles Dufour is a notable inventor based in Wanze, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address pulmonary inflammatory diseases. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Dufour holds a patent for "Cyclodextrin and budesonide derivative compositions and methods." This invention relates to novel pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative. These compositions are designed for the treatment and prevention of pulmonary inflammatory diseases. Additionally, the patent introduces a novel analytical technique for detecting and quantifying HP-β-CD in solution. Specifically, it utilizes validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without the need for extraction or separation steps for liquid formulations. He has 1 patent to his name.

Career Highlights

Throughout his career, Gilles Dufour has worked with various institutions, including the Université De Liège. His research and development efforts have significantly advanced the understanding and treatment of respiratory conditions. Dufour's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry.

Collaborations

Dufour has collaborated with notable colleagues such as Didier Cataldo and Brigitte Evrard. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Gilles Dufour's contributions to pharmaceutical compositions demonstrate his commitment to innovation in healthcare. His patent for cyclodextrin and budesonide derivative compositions highlights the potential for improved treatments for pulmonary inflammatory diseases. Dufour's work continues to inspire advancements in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…